Forest to co-promote Sankyo Benicar
Executive Summary
Forest Laboratories will co-promote Sankyo's anti-hypertensive agent Benicar (olmesartan) in a deal announced Dec. 12. The drug will be detailed by a combined sales force of approximately 1,200 reps. Sankyo filed the Benicar NDA July 27, 2000; FDA deemed the product "approvable" Oct. 24. The companies expect to launch the product in the first half of 2002...